Neuralink First Human Implant

Elon Musk announced on Jan 29, 2024 that the first person had received a Neuralink brain implant. As of Nov 9, 2026 Neuralink's last published count is 21 trial participants (Jan 28, 2026), the device is still investigational, and its Blindsight vision implant has no registered human trial.

26:06 As of Nov 9, 2026, Neuralink's implant is in people: the company's last published count was "21 Neuralnauts enrolled in trials worldwide" on Jan 28, 2026, with studies registered in the US, Canada, the UK and the UAE, and in Oct 2026 it published early speech results in people with ALS (Neuralink). It is still a trial device: Neuralink says its devices "are investigational and have not been approved by the FDA". Musk announced the first implant on Jan 29, 2024: "The first human received an implant from @Neuralink yesterday and is recovering well." That came about 14 months after the date he gave in the clip, from Neuralink's Show and Tell of Nov 30, 2022, where he says "probably in about six months" a Neuralink should be in a human.

Status: Delivered. Last checked: Nov 9, 2026.

Quick facts

Maker	Neuralink
First human implant	Announced Jan 29, 2024 (Musk on X)
FDA	First human study approved May 25, 2023 (Neuralink); device investigational
Participants	21, Neuralink's count of Jan 28, 2026 (Neuralink)
Blindsight	No registered human trial (ClinicalTrials.gov)

What he announced

19:06 The first public promise came at Neuralink's launch event on Jul 16, 2019, where Musk says the company hopes "aspirationally" to have the device "in a human patient before the end of next year", meaning 2020. The device he described then became the N1 Implant, which Neuralink calls the Link: 1,024 electrodes on 64 threads thinner than a hair, placed in the brain by its R1 surgical robot, wireless and recharged through the skin. Its first product, Telepathy, lets a person with paralysis move a cursor, type and play games by intending to move a hand.

The Jan 29, 2024 post added that "initial results show promising neuron spike detection". The first participant, whom Neuralink calls Noland, joined its PRIME study, a trial of whether the Link is safe and useful for people with paralysis (Neuralink).

The promises

Promised	When he said it	What happened
A device in a human "before the end of next year" (2020)	Jul 16, 2019, launch event	First implant in Jan 2024 (Musk on X)
A human implant "in about six months" (mid 2023)	Nov 30, 2022, Show and Tell	FDA approved the first human study on May 25, 2023; first implant Jan 28, 2024
First Blindsight implant in a blind person "later this year" (2025)	Late Mar 2025, Wisconsin event (Newsweek)	Not done
First Blindsight participant, and electrodes tripled to 3,000, in 2026	Jun 27, 2025, Summer Update	No Blindsight study on ClinicalTrials.gov and no 3,000-electrode implant in Neuralink's updates (read Nov 9, 2026)
"High-volume production" and an "almost entirely automated" surgery in 2026, threads through the dura	Dec 31, 2025, post on X	First surgery through the dura in May 2026 (Neuralink); no production figures published

Patients, by Neuralink's own counts

Date	Participants	Source
Jan 28, 2024	1 (Noland, PRIME)	Musk on X
Jul 2024	2 (Alex)	Neuralink, Aug 21, 2024
Feb 5, 2025	3 (Noland, Alex, Brad)	Neuralink
Jun 27, 2025	7	Summer Update
Jan 28, 2026	21	Neuralink

Neuralink has published no newer total as of Nov 9, 2026; counts higher than 21 seen online are tallies by fans, not the company.

What happened since

The first problem, May 2024. In the weeks after Noland's surgery, Neuralink wrote on May 8, 2024, "a number of threads retracted from the brain", which cut the number of working electrodes and his speed. The company changed its recording and decoding software, and says his performance then passed where it started.

FDA designations. The FDA gave Breakthrough Device Designation to Blindsight on Sep 17, 2024 and to a speech restoration device on May 1, 2025. The designation speeds review; it is not an approval.

More studies and money, 2024 to 2025. Beyond PRIME in the US, Neuralink registered CAN-PRIME in Canada (Nov 2024), UAE-PRIME (May 2025), GB-PRIME in the UK (Jul 2025) and the VOICE speech study (Oct 2025), and those five studies list 44 participants in their estimated enrollment (ClinicalTrials.gov, read Nov 9, 2026). It closed a $650 million Series E on Jun 2, 2025.

22:03 The roadmap, Jun 27, 2025. In the clip from Neuralink's Summer Update, co-founder DJ Seo gives the plan: speech decoding the next quarter, then in 2026 tripling the electrodes "from 1,000 to 3,000" and "our first Blindsight participant to enable navigation", then 10,000 channels and multiple implants in 2027. Musk had told a Wisconsin audience three months earlier that the first Blindsight implant would come in 2025 (Newsweek).

2026. Musk wrote on Dec 31, 2025 that Neuralink would start "high-volume production" in 2026 and that threads would go through the dura "without the need to remove it". In May 2026 Neuralink and Dr. Lozano's team at UHN in Toronto performed the first such transdural surgery, the company's video says. On its speech restoration page, Neuralink puts its median VOICE participant at roughly 50 words a minute (read Nov 9, 2026), and on Oct 23, 2026 it shared early speech results in ALS published in the journal Muscle & Nerve (Neuralink). Neuralink's trials page offers two studies, device control and speech; Blindsight is not among them.

Why "delivered": what Musk announced on Jan 29, 2024, a first human implant, happened, years after the dates he first gave, and the device has since gone into at least 21 people. It is not an approved product, and the vision implant he paired it with is late on both dates given for it.

We think

We think Neuralink announces its first human Blindsight implant before the end of Jun 2027, most likely outside the US first, as its device-control trials expanded to Canada, the UAE and the UK within 18 months of the first implant. The company has held FDA breakthrough status for Blindsight since Sep 2024 and named 2026 for its first participant, but no Blindsight study is registered as of Nov 9, 2026, so a 2026 implant is now unlikely.

Confidence: Possible. Check by: Jun 2027.

We expect Neuralink's next published participant count, whenever it comes, to be at least 40, roughly double the Jan 2026 figure, because its five registered implant studies list 44 participants and Musk said surgery would move to high volume in 2026.

Confidence: Likely. Check by: Mar 2027.